Open AccessValidation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in a retrospective cohort of children and adolescents who received an allogeneic transplantation in Argentina
Author(s) -
Carlos M. Figueroa Turienzo,
Carolina Cernadas,
Mariana Roizen,
Silvia Pizzi,
Raquel Staciuk
Publication year - 2016
Publication title -
archivos argentinos de pediatría
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 19
eISSN - 1668-3501
pISSN - 0325-0075
DOI - 10.5546/aap.2016.eng.337
Subject(s) - medicine , retrospective cohort study , transplantation , comorbidity , hematopoietic stem cell transplantation , cohort , hematopoietic cell , cohort study , haematopoiesis , stem cell , biology , genetics
Hematopoietic cell transplantationis a therapy with a risk of transplant-related mortality (TRM), which may vary depending on prior comorbidities. The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) is an instrument developed to measure this risk. There are very few reports on its use in pediatrics. The objective of this study was to validate the HCT-CI in a pediatric cohort of allogeneic hematopoietic-cell transplantation recipients in Argentina.